Actively Recruiting

Phase Not Applicable
Age: 6Years - 16Years
All Genders
ID06697275

Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia: Randomized Multicenter Trial

Led by University Hospital, Clermont-Ferrand · Updated on 2025-12-04

120

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Children and adolescents aged 6 to 16 years with acute leukemia often experience painful and anxiety-inducing treatments, especially during needle insertions into implantable ports used for administering chemotherapy and other therapies. This trial evaluates whether repeated use over three months of interactive or hypnotic virtual reality (VR) can better manage pain and reduce anxiety for the child, their parents, and caregivers compared to the standard distraction methods during these procedures. Participants are randomly assigned to one of three groups: the standard method involving local anesthetic cream and distraction by caregivers or parents, interactive virtual reality using a VR mask with guided virtual environments, or hypnotic virtual reality using a similar mask but with hypnotic software. In both VR groups, the child wears headphones and a headset and is immersed in a virtual world starting about five minutes before the needle insertion and continuing briefly after the procedure, with local anesthetic cream applied in all groups. During the study, children and their parents will be assessed for pain and anxiety using self-evaluation scales, heart rate monitoring, and satisfaction questionnaires after each needle insertion over a three-month period. Pain is primarily measured 15 minutes after the procedure. Researchers will also monitor fear levels and heart rate before and immediately after care to understand the impact of VR on the experience. The total participation spans these repeated care sessions during the three months following randomization.

CONDITIONS

Brief Title

Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia

Who Can Participate

Age: 6Years - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged 6 to 16 years with leukemia requiring needle insertion into an implantable port
  • Life expectancy of 3 months or more
  • Informed consent given by the child and their parents
  • No contraindications to MEOPA� (including no need for 100% oxygen ventilation, no intracranial hypertension, no altered consciousness preventing cooperation)
  • No contraindications to virtual reality mask use (no epilepsy or psychiatric illness)
  • Ability of child and parents to use self-assessment scales
  • Enrollment in the Social Security system
Not Eligible

You will not qualify if you...

  • Children with altered pain processing conditions (e.g., spina bifida)
  • Children requiring contact isolation due to contagious conditions
  • History of seizures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 3 months

Participants receive repeated weekly needle insertions into an implantable port with one of three methods: standard care with local anesthetic cream and distraction, interactive virtual reality with local anesthetic cream, or hypnotic virtual reality with local anesthetic cream. The virtual reality sessions include preparation, immersion during needle insertion, and a short period after the procedure.

Weekly visits for needle insertion and virtual reality or standard care

Follow-up

Duration - Up to 3 months after randomization

Participants' pain, fear, heart rate, and care evaluation are assessed during and after the treatment period to monitor outcomes.

Assessments occur before, immediately after, and 15 minutes after each care session

Trial Site Locations

Total: 4 locations

1

CHU de Bordeaux

Bordeaux, France, 33000

Actively Recruiting

2

CHU de Clermont-Ferrand

Clermont-Ferrand, France, 63000

Actively Recruiting

3

Assistance Publique - Hôpitaux de Marseille

Marseille, France, 13005

Actively Recruiting

4

CHU de Toulouse

Toulouse, France, 31059

Actively Recruiting

Loading map...

Research Team

L

Lise LACLAUTRE

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

3

Similar Trials

A First-in-Human Study of HLA-Partially to Fully Matched All...

Acute Leukemia

Actively Recruiting

9 locations

Linking From an Artificial-Intelligence Driven Assessment of...

Virtual Reality

Actively Recruiting

1 location

A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) ...

Acute Leukemia

Actively Recruiting

102 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here